Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Mar
24
2020
The Global Patent Race for a COVID-19 Vaccine Summa PLLC
Nov
17
2021
Intellectual Property Consolidation in the Agriculture Industry Summa PLLC
May
27
2022
Legal Protections for Food Safety Whistleblowers Katz Banks Kumin LLP
Jul
9
2020
Former JUUL Employee Seeks Injunction Against Pre-Employment NDA Katz Banks Kumin LLP
Sep
11
2020
California Supreme Court Clarifies Bounds of Legitimate Competition Under Tort and Antitrust Law The National Law Review's Guest Contributors
May
12
2020
Patentability of COVID-19 Biotech, Pharma & Personal Protective Equipment Inventions Global IP Counselors
May
13
2020
Patentability of COVID-19 Software Inventions: Artificial Intelligence (AI), Data Storage & Blockchain Global IP Counselors
Jun
8
2020
Are Qualified Patients Unqualified Parents? University of Missouri School of Law
Oct
7
2020
October 2020 Talc Lawsuit Update: Johnson & Johnson Agrees to Pay $100 Million Settlement Console and Associates, P.C.
Nov
2
2021
ESG’s Unintended Consequence – Lawsuits CMBG3 Law
Mar
16
2022
Washington PFAS Ban For Cosmetics Stalls CMBG3 Law
Dec
22
2022
Heinz PFAS Consumer Fraud Lawsuit Continues 2022 Trend CMBG3 Law
Aug
10
2023
TRI PFAS Obligations May Expand Considerably CMBG3 Law
Jun
22
2021
PFAS Medical Monitoring Costs – The New Litigation Trend? CMBG3 Law
Feb
28
2022
Prop 65 Lists PFOA As Carcinogen CMBG3 Law
Oct
1
2020
Chlorpyrifos Regulatory Actions Closely Watched By Litigators CMBG3 Law
Dec
8
2021
Ethylene Oxide Litigation Update CMBG3 Law
Jan
10
2022
Cosmetics and PFAS: Industry Lawsuits a Lesson For ESG CMBG3 Law
May
12
2022
SAB PFAS Report May Be Finalized This Week CMBG3 Law
Jul
28
2022
Rhode Island PFAS Regulations Become Law CMBG3 Law
Aug
31
2023
PFAS AFFF MDL Settlements Moving Forward CMBG3 Law
Nov
1
2023
PFAS Consumer Fraud Lawsuit Update: New Protein Supplement Case In NY CMBG3 Law
Jun
4
2021
FDA Ban On PFAS In Food Packaging Brought To Forefront CMBG3 Law
Jun
21
2021
PFAS In Cosmetics: Financial and Insurance Companies On Notice CMBG3 Law
Jul
5
2022
Current Trends in Legislation – June 2022 CMBG3 Law
Jul
25
2022
SAB PFAS Hearing Delivered News of Wider PFAS Regulation Possibility CMBG3 Law
Jul
29
2022
NAS PFAS Report Will Influence Lawsuit Trends CMBG3 Law
Feb
11
2021
Heavy Metals In Baby Food Pose Concern For Baby Food Industry CMBG3 Law
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins